<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Drugs for Treatment; Draft Guidance for Industry; Extension of the Comment Period</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Drugs for Treatment; Draft Guidance for Industry; Extension of the Comment Period</h1>
    <p class="timestamp">Published: 2016-06-27 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or we) is extending the comment period for the notice of availability, published in the Federal Register of May 4, 2016 (81 FR 26805), announcing the draft guidance for industry entitled "Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Drugs for Treatment." We are taking this action due to maintenance on the Federal eRulemaking portal from July 1 through July 5, 2016.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2016-15098</p>
    <p><strong>Publication Date:</strong> 2016-06-27</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2016/06/27/2016-15098/chronic-hepatitis-c-virus-infection-developing-direct-acting-antiviral-drugs-for-treatment-draft">https://www.federalregister.gov/documents/2016/06/27/2016-15098/chronic-hepatitis-c-virus-infection-developing-direct-acting-antiviral-drugs-for-treatment-draft</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2016-15098</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
